Certolizumab pegol bulk supplier for pharma manufacturers

Certolizumab Pegol 200mg Suppliers & Bulk Manufacturers

Available Forms: injection (prefilled syringe)

Available Strengths: 200mg

Reference Brands: Cimzia (USA/EU)

Certolizumab pegol is a PEGylated (polyethylene‐glycol) Fab′ fragment of a humanized anti-TNF-α monoclonal antibody that lacks the Fc portion. It works by binding to tumour necrosis factor-alpha (TNF-α) and neutralising its inflammatory effects, thereby reducing immune-mediated inflammation in various autoimmune conditions.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Certolizumab Pegol — third party manufacturing & bulk supply

Certolizumab Pegol 200mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Certolizumab Pegol is supplied as injection (prefilled syringe) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Certolizumab Pegol listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Certolizumab Pegol →

Back to Listing

Frequently Asked Questions

Certolizumab pegol is listed as injection (prefilled syringe) in 200mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Certolizumab pegol is referenced against Cimzia (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.